Penn Medicine Provider
Ophthalmology
Madhura A. Tamhankar, MD
4.9
(920)
Accepting new patients
Sees patients age 18 and up
Scheie Eye Institute Penn Presbyterian
Make an appointmentCall 215-662-8100

About me

  • Associate Professor of Ophthalmology at the Hospital of the University of Pennsylvania
  • Associate Professor of Ophthalmology in Neurology

Education and training

  • Medical School: Lokmanya Tilak Municipal Medical College
  • Residency: Nair Hospital
  • Residency: St. Mary's Hospital
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
4.9

926 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
very happy with my treatment
May 2025
5.0
5.0
she listened to me
April 2025
5.0
5.0
the provider has well educated and informed specialists that are properly qualified to readily answer patients questions regarding their medical needs.
April 2025
5.0
5.0
thorough and explains well

Insurance accepted

My Locations

Learn about location

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Tamhankar is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Yuanyuan Chen, Taylor Linaburg, Sarah Wang, Gibran Merchant, Tejus Pradeep, Patrick Anthony Augello, Gui-shuang Ying, César A. Briceño, Madhura A. Tamhankar Observational Characterization of the Re-treatment Course of Patients with Thyroid Eye Disease , Journal of Neuro-ophthalmology: 2025

Dogra N, Redmond BV, Lilley S, Johnson BA, Lam BL, Tamhankar M, Feldon SE, Fahrenthold B, Yang J, Huxlin KR, Cavanaugh MR. Vision-related quality of life after unilateral occipital stroke. , Brain Behavior, 14(7): 2024

Tamhankar MA, Raza S, Brutsaert E, Urdániz E, Vainilovich Y, Heyes A, Gildea L, Sales-Sanz M. The burden of illness in thyroid eye disease: current state of the evidence. , Front Ophthalmol (Lausanne)., 5: 2025

Rennie L. Rhee, Girish Bathla, Ryan Rebello, Robert M. Kurtz, Mats Junek, Kenneth J. Warrington, Nader Khalidi, Peter A. Merkel1, Konstanze V. Guggenberger, Madhura A. Tamhankar, Thorsten A. Bley for the Vasculitis Clinical Research Consortium Vessel wall MRI in giant cell arteritis: standardized protocol and scoring approach developed by an international working group , Rheumatology, 64(5): 2025,2910-2918

Taylor J. Linaburg MD, Tejus Pradeep, Yuanyuan Chen, Brian Rinelli, Yineng Chen, Gui-Shuang Ying, César Briceño, Madhura Tamhankar Ophthalmic Surgeries in the Pre-Teprotumumab and Teprotumumab Era , NANOS Scientific Abstract , Hawaii: 2024

Fahrenthold BK, Cavanaugh MR, Tamhankar M, Lam BL, Feldon SE, Johnson BA, Huxlin KR. Training in Cortically Blinded Fields Appears to Confer Patient-Specific Benefit Against Retinal Thinning , Invest Ophthalmol and Vis Sci, 1(65(4)): 2024,29

Madhura Tamhankar, Tejus Pradeep, Yuan Yuan Chen, Cesar Briceno Real world experience with teprotumumab in the treatment of patients with dysthyroid optic neuropathy , Journal of Neuro-ophthalmology , 44(1): 2024,74-79

Kasi S, Volpe NJ, Pistilli M, Tamhankar MA Effectiveness of Medial Rectus Advancement Alone or in Combination with Resection or Lateral Rectus Recession in the Management of Consecutive Exotropia. , JAAPOS, 17(5): 2013,465-470

Madhura Tamhankar, Brady kwong Maxwell Pistilli Benefits and side effects of prisms in the management of diplopia in adults: a prospective study , Journal of the American Association for Pediatric Ophthalmology and Strabismus. , 25(2): 2021,85.e1-85.e6

Kruszewski AM, Tamhankar MA. Ophthalmic Manifestations of Giant Cell Arteritis , Int Ophthalmol Clin, 63(2): 2023,13-23

View all publications